Botulinum a toxin    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
118Myelomeningocele1

118. Myelomeningocele    [ 9 clinical trials,   15 drugs,   (DrugBank: 7 drugs),   8 drug target genes,   11 drug target pathways]
Searched query = "Myelomeningocele", "Myeloschisis", "Myelocele", "Myelocystocele", "Syringomyelocele"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 9 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00175123
(ClinicalTrials.gov)
May 20059/9/2005Effect of Botulinum Toxin in Neurogenic Bladders in Children With MyelomeningocelePhase 4 Study of the Effect of Botulinum-A Toxin Injected in Neurogenic Overactive Bladders of Children Born With MyelomeningoceleMyelomeningocele;Bladder, NeurogenicDrug: Botulinum A toxinUniversity of AarhusAarhus University HospitalActive, not recruiting2 Years16 YearsBoth30Phase 4Denmark